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ABSTRACT
Objectives: To develop a digital intervention to
prompt, support, and respond to the outcomes of total
skin self-examinations (TSSEs) at home by people
treated for cutaneous melanoma.
Design: A complex intervention development study.
Setting: Northeast Scotland.
Participants: Semistructured scoping interviews;
people previously treated for cutaneous melanoma
(n=21). Pilot testing: people treated for melanoma
stages 0–2C (n=20); general practitioners (n=6); and a
nurse specialist in dermatology (n=1).
Intervention: A tablet-based digital intervention
designed to prompt and support TSSEs comprising
instructional videos and electronic reporting (including
photographs) to a clinical nurse specialist in
dermatology, with subsequent clinical triage.
Primary and secondary outcome measures:
Qualitative assessment of intervention feasibility and
acceptability, and quantitative assessment of
intentions and confidence to perform TSSEs in pilot
participants.
Results: The majority of pilot participants were
strongly positive and adhered well to the intervention
(n=15), with 7 of these reporting symptoms of
concern at some point during the 6-month pilot. 4
patients complied intermittently, 3 reporting skin
problems at least once during the pilot, and 1
withdrew. 2 patients underwent skin surgery as a
result of participating in the pilot, with 1 diagnosed as
having a recurrent melanoma and the other, a benign
lesion. A number of practical issues to improve the
usability of the intervention were identified. The
proportion of participants reporting intention to check
their skin at least monthly increased during the
intervention as did confidence to conduct a skin
check.
Conclusions: People previously treated for cutaneous
melanoma are prepared to use digital technology to
support them in conducting TSSE. An intervention has
been developed which is practical, effective and safe,
and after addressing minor practical issues, could now
be evaluated for clinical outcomes in a randomised
clinical trial.
INTRODUCTION
People previously treated for cutaneous mel-
anoma are at risk of recurrences and devel-
oping new primary melanomas.1 2 The early
detection of these events is one of the key
aims of structured follow-up programmes for
cutaneous melanoma, and these are sup-
ported by guidelines in most countries.1 3 4
Delivering effective structured melanoma
follow-up to a growing population of eligible
people is burdensome to health services.5
Furthermore, many recurrences and new pri-
maries occur in the intervals between struc-
tured melanoma follow-up visits.1 6 In
recognition of this, guidelines advocate that
patients treated for cutaneous melanoma
should be instructed to perform total skin
self-examinations (TSSEs), and to conduct
these examinations regularly in the intervals
between structured follow-up visits.1 4
There are reasons to believe that such
regular TSSEs performed by people previ-
ously treated for cutaneous melanoma could
yield marked survival beneﬁts.7 8 For
example, those who detect their own recur-
rences may have as much as a 63% reduction
in mortality.9 Furthermore, a review of the
efﬁcacy of skin self-examination for early
detection of melanoma found evidence of
Strengths and limitations of this study
▪ The study involved all key stakeholders in melan-
oma follow-up programmes.
▪ The study followed a well-evidenced and iterative
approach to developing theory, devising an inter-
vention, and establishing its feasibility and poten-
tial efficacy and a real-world clinical environment.
▪ The pilot is on a small scale, which has implica-
tions about the representativeness of our partici-
pants. A randomised clinical trial is now required
to inform wider implementation.
Murchie P, et al. BMJ Open 2015;5:e007993. doi:10.1136/bmjopen-2015-007993 1
Open Access Research
group.bmj.com on August 7, 2015 - Published by http://bmjopen.bmj.com/Downloaded from 
high speciﬁcity (83–97%) for the detection of new
lesions.10 Sensitivity was lower, but the included studies
were not conducted with those previously treated for
melanoma. It seems likely, although it cannot be stated
with certainty, that a previous diagnosis of melanoma
would increase knowledge and awareness with a corre-
sponding increase in sensitivity. There is also some evi-
dence, from a US case control trial and Australian
modelling paper, that skin self-examination can reduce
the development of advanced disease and facilitate early
detection of recurrence by people affected by melan-
oma.9 11 It is hoped that support to perform TSSEs
could enable both recurrences and new primaries to be
detected at a much earlier stage when a cure may still be
possible. The risk of recurrence in cutaneous melanoma
is inﬂuenced by the stage of disease at diagnosis.11 Less
intense follow-up regimens have been advocated for
those with early-stage disease at diagnosis (stage IA, IB,
IIA), and effective and sustained TSSEs could be par-
ticularly important in underpinning these.11 Equally,
however, since all patients treated for cutaneous melan-
oma are at risk of recurrence, effective TSSEs could be
viewed as having a role as an adjunct in follow-up irre-
spective of the clinical stage at diagnosis.
Despite this, TSSEs education and practice appears
suboptimal with 70% of American patients with melan-
oma indicating that they have never been advised to do
it.12 We have found similar evidence of under-prepared-
ness to conduct TSSEs in a UK population.13
Evidence from randomised trials suggests that people
can be appropriately trained to conduct TSSEs.14–18
However, it is less clear whether TSSEs, once learned,
can be sustained. Recent qualitative evidence suggests
that the intention to conduct TSSEs wanes with time.13
Digital technologies are becoming more prevalent in
society, with a recent report that 49% of UK homes own
at least one smartphone, tablet and computer.19 More
and more people are using personal electronic devices,
such as tablets and smartphones, to obtain health infor-
mation and to interact with healthcare providers.20 This
paper reports the development, pilot testing and prelim-
inary evaluation of the Achieving Self-directed
Integrated Cancer Aftercare (ASICA) intervention, a
tablet computer-based application designed to prompt
and support TSSE at home by people treated for cutane-
ous melanoma.
DEVELOPING AND PILOTING THE ASICA INTERVENTION
Overview
Our approach was based on the key development activ-
ities outlined in the Medical Research Council (MRC)
Framework for the development and evaluation of
complex healthcare interventions.21 22 Our developmen-
tal approach comprised a number of activities.
Generated evidence on how technology has been used in
cancer follow-up, how people with melanoma perceived
this technology that could be used to support them to
conduct TSSEs, and how to target technology at those
patients with the most potential to beneﬁt.
Identiﬁed and developed theory grounded in Information–
Motivation–Behaviour skills (IMB) as an explanatory model
combined with Control Theory and Implementation
Intentions to underpin the theoretical development of the
intervention.23–27 The IMB model proposes three requisites
for engaging in preventive behaviours: individuals must
have access to relevant information; be motivated to act;
and be capable and conﬁdent (self-efﬁcacious) enough
to carry out the behaviour in question. IMB has been
used successfully to explain and change health relevant,
preventive behaviours; for example, an IMB-based inter-
vention was more effective than information alone in
increasing HIV prevention behaviour (condom use) in
truck drivers.23 28 Control theory, ﬁrst proposed in 1982,
proposes that behaviour is maintained through monitor-
ing and evaluation of the discrepancy between goals and
current behaviour via a discrepancy-reducing feedback
loop.25 29 30 A speciﬁc goal (eg, performing TSSE) is
compared with current behaviour and if a discrepancy is
detected, action is taken to bring behaviour closer in line
with the goal. If the behaviour gets closer to the goal in
response to feedback, the behaviour persists; however, if
the discrepancy is perceived to be too great, the individ-
ual may disengage from the behaviour. Interventions
based on Control Theory are consistently shown to be
effective in changing health-related behaviours in clinical
and non-clinical populations.31 For example, in a metare-
gression examining interventions to change
health-related behaviours in 122 studies, the most effect-
ive interventions included techniques based on Control
Theory (self-monitoring goal setting, specifying action
goals, feedback and review of goals).32 A third model
used in the current study concerns ‘implementation
intentions’ or ‘action plans’.26 27 Action Plans are short
‘if-then’ plans that have been shown to be effective in
enabling individuals to achieve their behavioural goals in
a wide range of contexts. Thus, IMB theory proposes the
factors needed to engage in target behaviour—informa-
tion, motivation and skills/conﬁdence, and Control
Theory and Action Plans indicate the processes necessary
to keep the behaviour going (goal prioritisation, feed-
back, behavioural discrepancy detection), and the techni-
ques that can be used to help individuals achieve and
maintain target behaviours. Using these models, the com-
ponents for a potential intervention were theorised in
consultation with experts in behavioural science, and the
mechanism for the whole intervention to prompt, record
and respond to TSSEs by patients in their own homes was
conceptualised and implemented using Behaviour
Change Techniques (BCTs).
Modelled the process of delivery of the combined compo-
nents of the intervention. A major challenge to this
project was to combine the theory and evidence-based
components into a viable intervention, and we used
innovative methods to simulate the full intervention. This
was carried out using an Experience Laboratory event
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facilitated by experts where healthy volunteers simulated
the processes of the theorised ASICA intervention.
Once the prototype ASICA intervention had been
developed, we assessed the feasibility and acceptability of
the prototype ASICA intervention (ﬁgure 1) through a
pilot exercise with a group of patients supported by a
nurse specialist in dermatology.
DEVELOPING THE ASICA INTERVENTION
Generating the evidence to use and target technology
Evidence was derived from three sources. First, a sys-
tematic review was conducted to determine how tech-
nology has been used to support people with cancer.
The methodology and results of this systematic review
are reported in detail elsewhere.33 Second, interviews
were conducted with 21 people previously treated for
cutaneous melanoma. Full ethical approval for the
interviews was sought from the North of Scotland
Research Ethics Committee and granted on 2 May
2012. The methodology and results of these interviews
are reported in detail in a previous publication.13
Third, clinical data were sought and obtained, where
available, on recent recurrences and new primary mela-
nomas diagnosed in Northeast of Scotland. The
methods to obtain, analyse and interpret these data
have been reported in detail.6
Figure 1 TSSEs procedure as supported by the ASICA application (ASICA, Achieving Self-directed Integrated Cancer
Aftercare; SMS, short message service; TSSEs, total skin self-examinations).
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When integrated, this evidence suggests that the tech-
nology to deliver cancer follow-up care remotely is avail-
able, safe and acceptable. Furthermore, people treated
for cutaneous melanoma can see the beneﬁt of conduct-
ing TSSEs, but feel ill-equipped to perform it properly,
safely, regularly and sustainably. They can, however, see
the potential of technology to support them in this
endeavour and want to be shown how to conduct
sequential TSSEs, and then be reminded about when
and how to do it. They also believe that this process
could be supported by repeated reference to an instruc-
tional resource (eg, a video) and self-reference (eg, a
digital skin map). Once they have conducted a TSSE,
they want to be able to report their ﬁndings quickly to a
specialist, and be reassured that the specialist would
check their report and respond quickly if there were
concerns. They would also welcome the potential oppor-
tunity to engage with healthcare professionals from their
own homes without inconvenience (travel, time off
work, parking). This was especially so for rural dwellers.
The evidence garnered from the literature and inter-
views also found that potential recipients strongly felt
that approaches to monitor potential recurrence need
to be developed carefully, and should not replace
current hospital-based follow-up until their safety and
efﬁcacy have been proven. The clinical data also sug-
gested that recurrence is relatively common, occurs early
and is usually found at the follow-up clinic within the
ﬁrst year. Therefore, an intervention to support TSSEs
should be implemented within a month or so of diagno-
sis to afford maximum beneﬁt.
Identifying and developing theory
The research team included an academic general practi-
tioner (GP), a health services researcher, two health psy-
chologists, and two computer scientists. Together, they
had expertise in intervention development and evalu-
ation, behaviour change and translating behavioural
interventions into programmed computer applications.
The chief investigator (an academic GP) ﬁrst conceptua-
lised the aims, processes and outcomes that the digital
intervention should achieve. The ﬁnal theoretical inter-
vention was then produced in a series of three consensus
meetings involving the whole research team.
The overriding aim of the intervention was to prompt
the performance and reporting of good quality TSSEs by
people previously treated for cutaneous melanoma. To
achieve this, individuals must be shown how to use tech-
nology to conduct optimal TSSEs and then be prompted
to conduct TSSEs regularly. They need to be able to
remind themselves how to undertake TSSEs when they
are due to do it. The intervention must then transmit
the result of each patient’s TSSEs to an overseeing clin-
ician, who will then respond appropriately (ie, employ
clinical triage) when a patient did identify a concern.
These aims, processes and outcomes were agreed at
the ﬁrst consensus meeting of the whole research team.
Consideration was then given to the most appropriate
theoretical model able to inform an intervention to
achieve these aims, support the necessary processes, and
deliver the desired outcomes.
By consensus with the research team, it was decided
that the IMB model offered the most promise in
explaining current use of TSSEs.23 Using this model, the
components for a potential intervention were theorised
(ie, components that would provide information about
TSSEs, motivate individuals to perform TSSE, and
develop skills and conﬁdence to perform TSSE) and the
mechanism to prompt, record and respond to TSSEs by
patients in their own homes was conceptualised. This is
illustrated in ﬁgure 2A, B.23 24
At a second consensus meeting, the results of the
interviews conducted at stage A were considered. It was
noted that while the explanatory outline was based on
the IMB, the results of interviews A indicated that
although patients required more information, they were
already highly motivated and we, therefore, required a
theory that guided the translation of motivation into
action. The psychologists proposed that the process of
the intervention should, therefore, incorporate Action
Planning and should be revised to be additionally
guided by ‘Control Theory’—as this theory deals with
the process of self-regulation to change behaviour from
a pattern that fails to achieve the person’s goal to one
that achieves their goal.23–25 Together, these theories
outline the process of change and give some guidance
on the BCTs (ie, the active ingredients that make up an
intervention and are required to change behaviour)
which the intervention required.34 Some techniques
were required to develop the knowledge and behav-
ioural skills to enact the behaviour (eg, demonstrating
the behaviour, rehearsing/practising TSSEs); some to
enhance/maintain the person’s motivation to engage in
the process of TSSEs (eg, providing information on
health consequences of the behaviour (TSSEs), using a
credible source for the information); some to enhance
conﬁdence that they could conduct TSSEs successfully
(eg, mastering the skills necessary); and some to enable
self-regulation of action, especially remembering when
to act (eg, prompts and cues), and the sequence of
actions necessary for the optimal clinical outcome (eg,
Action Planning, where patients who have decided to do
TSSEs would make a clear plan when, where, and how
they would do the examination). Planning ‘how’ to
perform TSSE might include involving someone else
(eg, to examine areas of skin that they cannot easily see
themselves), and planning ‘when’ to receive a reminder.
In addition, some techniques were designed to maintain
continued engagement in the behaviour (eg, receiving
feedback).26 27
To produce the ﬁnal theoretical intervention, a ﬁnal
consensus meeting was held. The whole research team
ﬁrst discussed the ﬁdelity of the theory to the delivery of
the intervention, and then worked together to map a
theoretical structure for the intervention, incorporating
the identiﬁed BCTs where appropriate. The intervention
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demonstrated the target behaviour (with a video clip);
enhanced motivation to perform TSSE (with recorded
information about the consequences of performing/not
performing TSSE); enhanced conﬁdence (with the
incorporation of step-by-step instructions and opportun-
ities to try each step in the video clip). The intervention
tackled the issue of intentional and non-intentional non-
adherence (including forgetting, deferring, avoidance
or deciding it is unnecessary) (using cues to prompt
individuals to undertake TSSEs); provided individuals
with feedback about the behaviour (by sending TSSE
results to health professionals and getting the profes-
sional reply); and checked adherence to TSSE (by
asking individuals to mark skin maps/record how long
the personal skin check took). This gave an indication
of thoroughness and provides information on those who
Figure 2 (A) Model demonstrating theoretical processes of ASICA application according to IMB model—adapted from Cowling
et al.24 (B) Schematic demonstrating operationalisation of components and processes of ASICA intervention adapted from
Cowling et al24 (ASICA, Achieving Self-directed Integrated Cancer Aftercare; IMB, Information–Motivation–Behaviour skills;
TSSEs, total skin self-examinations).
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do it more quickly because, for example, they have
other commitments, or those who choose to adopt
avoidance. This allows the monitoring of adherence and
engagement. A strategy to identify avoidance is very
important since without it the clinicians could be
making clinical decisions and providing clinical advice
based on incorrect information.
Modelling the process of delivery of the intervention
Experience Laboratory event
An Experience Laboratory event was held in May 2013
at Glasgow School of Art’s Centre for Design Innovation,
in Forres, Moray.35 This facility enables the creation of
different environments to simulate real-life situations.
The processes of delivery for the ASICA intervention,
including simulation of the clinical sequences, were
developed for use at the event. This included a simula-
tion of the information and TSSEs demonstration for a
potential supporting digital application, which was pro-
duced and embedded on a hand-held tablet computer,
with guidance from experts in design and presentation.
Three locations were constructed: a patient’s bedroom
(see online supplementary photo), a GP’s clinic, and a
clinical nurse specialist’s ofﬁce, the latter two being
equipped with videoconferencing capability. The inter-
vention components included in the simulation were:
the cue to action (ie, the prompt to complete TSSEs);
the instructional video (showing how to conduct
TSSEs); the skin-map (to be used while conducting
TSSEs); and the report sent to health professionals (fol-
lowing completion of TSSEs).
The Experience Laboratory event was facilitated by
design experts and attended by ﬁve patient volunteers
(1 supported by a helper) unaffected by cutaneous mel-
anoma who performed a simulation of the theoretical
intervention (as shown in ﬁgure 2B), a GP, a clinical
nurse specialist in dermatology, and the researchers.
Following an initial brieﬁng session, an existing instruc-
tional video produced by MASScot (Melanoma Action
and Support Scotland) describing how to conduct TSSEs
was viewed by all participants. Two scenarios were con-
structed and enacted by each of the patient volunteers.
In the ﬁrst scenario, the volunteers were asked to
perform TSSEs for which no problems were detected. In
the second scenario, the volunteers conducted TSSEs at
which a new mole was detected. In this latter scenario,
the patients attended the GP surgery location for a video
consultation between themselves and the co-located GP,
and the remote clinical nurse specialist.
A professional TV company ﬁlmed and edited a video
of the proceedings. At the conclusion of the day, all par-
ticipants viewed the video, and a feedback and a debrief-
ing session was held.
Integrating components and processes of the ASICA
intervention
The Experience Laboratory enabled participating stake-
holders to articulate and agree on the beneﬁts which
the ASICA intervention could deliver to recipients.
Furthermore, the activity enabled the theoretical compo-
nents of the intervention to be operationalised in the
simulation in order to gain insight into how well these
integrated and served the purposes for which they were
intended, that is, to support the mechanism of prompt-
ing, recording, and enabling a response to TSSEs. The
Experience Laboratory also enabled the researchers to
gain insight into the detailed processes and the
sequence in which these should occur to support the
effective operation of the ASICA intervention. These
were: the language used; training of the user; reporting
to the specialist, and receiving feedback from the spe-
cialist. The detailed learning achieved on each compo-
nent is also summarised in online supplementary
appendix 1.
Combining processes and components in a prototype
intervention
As a result of the Experience Laboratory event, the
detailed components and processes identiﬁed and devel-
oped during the theoretical stage were integrated into a
prototype ASICA intervention, including a supporting
digital application which was designed to run on a
Google Nexus 7 tablet computer. Distinct from the appli-
cation were several other components including:
1. The structured training session required at inception;
2. The initial and recurring cue to action required to
remind the patient to conduct a personal skin check;
the need for this to be a separate trigger (sent by
email or text message to the recipient’s mobile
phone) was necessary to avoid the risk that the tablet
was used only for skin checks with the risk that the
prompt would not be received;
3. The specialist’s response, a telephone call from the
overseeing specialist’s nurse within 24 h, since both
the human contact and immediacy were perceived as
important reassuring factors at a time when a patient
could be anxious.
On the basis of the Experience Laboratory ﬁndings,
the prototype intervention was adjusted for piloting.
The need for clear and simple language unifying the
application and supporting processes was perceived to
be key to user engagement and intervention adherence.
Within the digital application, language was made con-
sistent with the language introduced at the training
session. This was carried over into an animated instruc-
tional video which was produced and divided into chap-
ters based on body areas, and used as a means to
demonstrate and remind users about the speciﬁc beha-
viours required to check their body. Conducting the per-
sonal skin check using the application was designed to
follow a logical sequence supported by a checklist for
self-monitoring of completion. The process of feeling
for lumps in regional nodal areas was routed so that
only the appropriate nodal area was examined by each
patient. Patients are also able to check an integrated
individualised skin map (formed of a series of
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professionally produced clinical photographs of each
patient) to determine whether skin lesions were new or
changing. This function was further supported by the
application storing previous reports/images for future
reference. At the conclusion of the skin-check, the
ASICA application delivers a message that either no
problem has been reported or in the event that a
symptom concern has been raised, that a specialist will
be in touch within 48 h with further advice. In either
eventuality, the completion of the TSSEs is recorded and
acknowledged giving a sense of completing the pro-
cesses in a way that provides feedback and reassurance;
this acts as a reward for completing the behaviour with
the aim of reinforcing the behaviour so that individual
patients will keep using the ASICA application.
PILOT STUDY OF THE FEASIBILITY AND ACCEPTABILITY
OF THE PROTOTYPE ASICA INTERVENTION
The prototype ASICA intervention, including the sup-
porting digital application, was subject to a pilot study of
feasibility and acceptability among 20 people who had
previously been treated for cutaneous melanoma.
Recruitment
Six practices were purposively selected to represent geo-
graphical spread within the National Health Service
(NHS) Grampian region of Scotland, and a GP from
each was invited to a training meeting to have the proto-
col explained. The lead GP at each practice identiﬁed
and approached potential participants for pilot study.
Eligible patients were aged over 18 years, had been
diagnosed and treated for cutaneous melanoma within
the preceding 5 years, were currently receiving hospital-
based follow-up, and had no nodal involvement or
metastases (ie, in situ to stage 2C). The 20 people agree-
ing to participate were identiﬁed to, and approached by,
the research team. The characteristics of participants are
shown in table 1. Recruits attended the Medical
Illustration Department at the University of Aberdeen to
have a full personal body mapping digital photography
taken. These were subsequently hosted on a secure
server and could be accessed by individual patients to
refer to during subsequent skin checks.
Participant training
Three training sessions (each of 2 h duration) were held
in Aberdeen. The meetings followed a structured pro-
gramme. Participants were introduced to the study and
its purposes. The fact that the intervention was experi-
mental (and additional) to their ongoing follow-up was
stressed to ensure default from follow-up was not sug-
gested. Participants were instructed in the use of the
application and tablet, including how to access their
digital skin maps, and their understanding and ability to
comply checked. Patients were given detailed instruction
manuals for the tablet and the application. The project
researcher arranged an individual meeting with one
individual who was not able to attend the training ses-
sions. To prepare for a future clinical trial a question-
naire was modiﬁed, with permission, from one used
previously.15–17 The questionnaire (included as online
supplementary appendix 2) sought information about
Table 1 Characteristics of pilot study participants
ID Age Gender Place of residence* Date of Mel Dx Site Stage
001 46 F Accessible rural 2010 Arm 1.1 mm stage 1B
002 49 F Other urban area 2012 Knee 0.5 mm stage 1A
003 72 F Accessible rural 2013 Arm 0.4 mm stage 1A
004 69 M Urban 2013 Breast 0.8 mm stage 1A
005 62 M Remote rural 2012 Eyelid M in situ stage 0
006 66 F Remote rural 2011 Cheek 0.3 mm stage 1A
007 72 M Remote small town 2009 Cheek 2.8 mm stage 2A
008 70 M Remote small town 2012 Shoulder 0.3 mm stage 1A
009* 41 F Remote rural 2011 Back >1 mm
010 67 F Accessible rural 2009 Arm 3 mm stage 2A
011 78 M Remote small town 2008 Eyebrow 2.6 mm stage 2A
012 42 F Accessible small town 2011 Back M in situ stage 0
013 75 F Accessible rural 2009 Thigh 1.1 mm stage 2B
014 67 M Accessible rural 2013 Shoulder 2 mm stage 2A
015 46 F Accessible rural 2011 Abdomen 0.6 mm stage 1A
016 72 M Accessible rural 2011 Forearm 1 mm stage 1B
017 65 M Accessible rural 2014 Shoulder M in situ stage 0
018 69 M Remote rural 2009 Shoulder 1.5 mm stage 1B
019 44 M Accessible rural 2012 Abdomen 1.5 mm stage 1B
020 44 F Accessible small town 2010 Lower leg 0.42 mm stage1A
Classifications from Scottish Government Urban-Rural Classification.38
*Staging data were not available for this patient.
M, melanoma; Mel Dx, melanoma diagnosis.
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respondents’ skin cancer history, their skin self-
examination practices and intentions, their attitudes,
beliefs, self-efﬁcacy, and intentions about conducting
skin self-examination, their Hospital Anxiety and
Depression scale, information about comorbidities and
their demographic characteristics. Participants were
asked to complete the questionnaire on arrival at their
initial training session. They were then sent the ques-
tionnaire again at the conclusion of the pilot.
Pilot study process
Participants were sent a monthly email reminding them
that it was time to conduct their personal skin check.
On receipt of the reminder, it was intended that they
would use the ASICA application to help them systemat-
ically examine their skin; through the application they
were able to view the integrated instructional video
chapters which enabled them to do their skin check. A
structured electronic report pro-forma was available for
completion. Where a new lesion was identiﬁed either at
the previous melanoma site or at a new one, participants
were able to complete a free-text description and/or
attach a photograph taken using the tablet’s camera
function. Completed reports were then sent electronic-
ally to a secure and remote server. The returned reports
were communicated to and reviewed by an overseeing
nurse specialist. Figure 1 illustrates the TSSEs procedure
supported by the ASICA application. Patients who had
identiﬁed concerns were contacted by telephone within
24 h by the reviewing nurse specialist, who either pro-
vided reassurance or invited them to an upcoming clinic
for subsequent review. At the conclusion of the pilot
study, all continuing participants were invited to attend a
total skin examination at their GPs’ clinic; 15 accepted
this invitation and attended the skin examination at
their GP’s clinic. Three declined, one because he was on
holiday at the time of the appointment, one because he
was undergoing treatment for metastatic melanoma.
A further one participant did not respond to the
invitation.
At the conclusion of the pilot, the project researcher
SH contacted all participating patients and the oversee-
ing clinical nurse specialist to conduct a brief telephone
interview. These interviews aimed to capture the prac-
tical experiences and personal reﬂection of participants
in the pilot study. These were conducted to identify par-
ticipants’ perceptions of strengths and weaknesses with
the components, or the process and delivery of the
intervention, so that subsequent improvements could be
made. The interviews were guided by a topic schedule.
Questions focused on patients’ perceptions of the
strengths and weakness of the ASICA application, and
how it had functioned. The interviewer also gathered
information about how well the technical aspects of the
intervention had worked from the nurse-specialist’s and
patient’s perspectives. The interviews were conducted by
telephone, and were recorded and transcribed for subse-
quent analysis and reﬂection by the research team.
As this was a pilot study, no a priori hypotheses were
determined based on clinical or psychological outcomes.
We did, however, ask participants to complete a ques-
tionnaire seeking information about clinical, behav-
ioural, and psychological outcomes to aid preparation
for a subsequent clinical trial.
Pilot study results
Feasibility
Details of the number and regularity of the skin checks
participants performed during the pilot can be seen in
table 2. Of the 20 participants, 15 complied well of
whom 8 reported no symptoms during the 6-month
pilot and 7 reported at least one issue to the overseeing
clinical nurse specialist. Most issues were resolved by sub-
mitting further images under the direction of the spe-
cialist nurse, with a corresponding telephone call. Two
participants subsequently had the lesions spotted during
personal skin checks removed, one was a recurrent mel-
anoma and the other was a benign lesion. Of the three
less-compliant participants, one regularly checked only
his face where his original primary melanoma had been,
while another checked selected areas less regularly, citing
work pressures and lack of time to conduct TSSEs.
Another, a busy mum who stated she found it difﬁcult to
make time to conduct a TSSEs, checked her skin only
once and on that occasion reported three issues of
concern to the overseeing nurse specialist. One partici-
pant withdrew from the pilot for undisclosed personal
reasons.
With respect to the technical operation of ASICA
application, the nurse specialist stated that on the few
occasions when photographs of new skin lesions had
been submitted by participants these were typically of
insufﬁcient quality on which to base clinical judgements.
However, in almost all cases he was able to contact the
patient and direct them to take improved images. As a
result, guidelines to take good-quality images have been
incorporated into the revised app.
Acceptability
Patients were largely positive about their experience of
using ASICA application. The user-friendliness of ASICA
application was highlighted along with views that partici-
pation supported good habits, allowed participants to
become familiar with their own bodies, and provided
them with empowerment and reassurance. Box 1
describes comments which reﬂect these themes.
Technical issues raised by patients fell into three categor-
ies. There were minor issues with the interface (eg, parts
of electronic buttons being obscured) which have been
modiﬁed. Some patients, especially those in the more
remote rural areas, were troubled by issues related to
their internet connections. These are less easy to
resolve, but are likely to be more common in this par-
ticular geographical location than in the majority of the
rest of the UK. Government initiatives and technological
advances will help going forward in this regard.
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Table 2 Compliance with intervention and outcome of monthly skin checks
Patient Month 1 (May) Month 2 ( June) Month 3 ( July) Month 4 (August) Month 5 (September) Month 6 (October)
Number
of body
areas
checked
Changes
reported
Number
of body
areas
checked
Changes
reported
Number
of body
areas
checked
Changes
reported
Number
of body
areas
checked
Changes
reported
Number
of body
areas
checked
Changes
reported
Number
of body
areas
checked
Changes
reported
N=8: complied well, reported no symptoms
P02 5 0 5 0 5 0 5 0 5 0 5 0
P03 0 0 0 0 5 0 5 0 5 0 0 0
P04 5 0 5 0 5 0 0 0 0 0 5 0
P05 5 0 5 0 5 0 5 0 5 0 5 0
P06 5 0 5 0 5 0 5 0 5 0 5 0
P10 5 0 5 0 5 0 5 0 5 0 5 0
P16 5 0 5 0 5 0 5 0 5 0 5 0
P19 5 0 0 0 5 0 0 0 5 0 5 0
N=7: Complied well, reported symptoms
P01 4 1 0 0 5 2 5 2 4 1 5 0
P07 5 3 5 5 5 2 5 0 5 2 5 0
P08* 4 0 5 0 5 0 5 2 5 0 5 1
P13 3 3 1 1 5 0 5 0 5 0 5 0
P14 0 0 3 2 4 0 5 1 5 0 4 0
P15 5 1 0 0 5 1 5 0 5 0 5 0
P18† 5 1 0 0 5 0 0 0 5 1 0 0
N=3: Complied less well, reported symptoms
P11‡ 1 1 1 1 1 0 1 1 1 1 1 1
P12 0 0 1 0 0 0 3 1 0 0 0 0
P17 0 0 0 0 3 3 0 0 0 0 0 0
N=1: Complied poorly, reported no issues (P20)
P20 0 0 0 0 0 0 0 0 5 0 0 0
P09 patient withdrew citing personal circumstances making skin checks difficult—not clear what these were
*P8 diagnosed with recurrent melanoma after excision of lesion noticed during personal skin check.
†P18 diagnosed with benign lesions on both legs after excision of lesions noticed during personal skin check.
‡P11 checked head and neck only.
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Similarly, there were some issues with the hardware,
for example, a malfunctioning charger in one case and
a damaged screen in another.
Piloting trial procedures
Sixteen participants completed and returned the ques-
tionnaire at baseline and outcome. The data are not pre-
sented in detail. There were non-signiﬁcant increases in
the proportion of respondents indicating that they
intended to check their skin at least monthly, and in the
proportion indicating that they would be conﬁdent to
perform TSSE. No signiﬁcant changes were observed
between baseline and outcome in anxiety, depression or
cancer worry. These data will, however, be informative in
determining power for a subsequent randomised trial.
DISCUSSION
Principal findings
The authors have developed a feasible clinical interven-
tion process based on a digital tablet-based application
to prompt, record, and respond to regular TSSE by
people previously treated for cutaneous melanoma. This
has proven to be acceptable and safe for patients to use.
There is also preliminary evidence that it can help
reinforce and sustain TSSEs in a way that has not previ-
ously been possible. Further, there is some early evi-
dence that it can bring new skin problems under
medical attention sooner than would otherwise have
been the case. It must also be noted, however, that the
fact that a minority of patients did not comply or com-
plied only partially indicates that ASICA application will
Box 1 Comments from patient interviews reflecting views on usability and acceptability
A user-friendly device
P03—“Yes, it was quite clear the actual information that we were given, very clear, beautifully set out, very easy to use and understand.”
P04—“Very good. Very good indeed. It’s very clear, easy to understand and useful in tips about parting your hair and getting somebody
else to check the back of it for you and things like that, yeah, very clear and easy to understand and you know, tips about how to do
awkward places on yourself, yes.”
P05—“So what I’ve done is have a good look at myself over the preceding days, if you know what I mean, just as and when it was comfort-
able. And really handy, when I was getting changes, getting up or going to bed or what have you, in the shower. And then just rattle
through the app.”
P08—“The animations that were provided I thought were a really good guide, for somebody that’s not used to technology it was really
simple.”
P17—“Well it tells you exactly what you need to know, there’s no question about that.”
P21—“The instructions were excellent, they were very well laid out. The videos were very helpful showing you exactly what you needed to
do and how to check yourself all over.”
Establishing good habits
P04—“But the fact that it makes people do it once a month or whatever, it focuses the attention because it’s something we’d probably be
a bit slapdash with normally.”
P13—“The tablet is great. Totally self-explanatory and the videos are very easy to watch and everything so it very easy to do and send off
the report. Everything was great.”
P15—“It made you really thorough about the skin check procedure. There was no way you could miss anything out. It was really good.”
P16—“Yes, as I say, it’s all clear and it’s really good to see every part of your body…to go through it all in separate stages. Yes, it make
you do it all in a through way, which is important, since I’m not getting checked at the hospital anymore, so it’s really important that I’ve
got to remember to check my whole body in case something appears.”
Getting to know my own body
P01—“I like having the maps to look at because I’ve got a lot of moles but I have discovered there might be a blind spot on my arms where
it’s not really getting my arm—if you know what I mean?”
P15—“Without this it becomes very difficult to remember if anything has changed very much since the last time you looked. This was
really the first time I’ve ever looked really closely at my body, and I think to myself “goodness, I didn’t realise I have that there before.”
And then I go back to the body map and—which is a salutary exercise in itself—and see “oh yes, it was there.” I suppose it’s getting to
know your body much better.”
P17—“I never used to think about it, but I know what to look for now. If I see something I know what it is, and what to do. Before, I never
would have noticed.”
P21—“The more I’ve done it over the period of months, the more that I’ve gotten used to where everything is on my body, where all the
different moles are.”
P21—“Before starting this project I probably wasn’t really checking my skin that much at all, but since I’ve been doing this, it’s been much
more regular and I’ve been paying much more attention to it.”
Feeling reassured and empowered
P09—“I’m very pleased with it, because it’s helping me, you feel in control, that you are looking after yourself.”
P12—“If somebody is checking it, that can get back to you really quickly, then off to the GP. Very re-assuring.”
P14—“And because I was doing it so diligently, I felt good about that.”
P14—“It a brilliant idea, especially for people who are a long way away, because you can do a really thorough check, and received profes-
sional reassurance without having to travel all the way to Aberdeen.”
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not compel all patients to conduct regular TSSEs or
might require tailoring for some patients.
Strengths and limitations
Strengths
The approach adopted for developing the ASICA inter-
vention had several inherent strengths. Developing inter-
ventions that employ digital technologies to deliver
aspects of healthcare in a completely new way is
immensely challenging. For this reason, our approach
beneﬁted from employing the structured, iterative, and
well-rehearsed approach advocated by the MRC frame-
work.21 22 The use of the Experience Laboratory allowed
simulation of the complete intervention, integrating
components based on theory and evidence. The experi-
ence of the team in following this approach, and the
strong theoretical underpinning of the IMB and Control
Theory models allowed the project to be phased and
focused.23 24 We involved key stakeholders—potential
patients, clinicians, technology specialists, behavior-change
intervention specialists, health service researchers—at
each stage of the process so that their perspectives were
identiﬁed and incorporated throughout. Furthermore,
adopting this multidisciplinary approach enabled an
ongoing understanding of the full spectrum of potential
challenges and caveats which the intervention was
required to overcome, complemented by an ability to
exploit the enablers perceived by each group. We were
also able to ensure that we optimised the potential of the
ASICA digital application by identifying the necessary
processes and components, and ensuring that these were
developed and embedded within the intervention in the
most effective way.
Limitations
Some limitations must be acknowledged. The pilot was
conducted on a small scale within Northeast Scotland.
Clearly, this has implications about the representative-
ness of our participants. In terms of the whole Scottish
population, they were relatively afﬂuent and also willing
to learn about technology. It was assumed that all
patients were physically capable of using the tablet and
the application; one patient who could not use the
ﬁngers had to be supplied with a stylus. There were
other disabilities that were not provided for, for
example, poor eyesight, lack of proﬁciency in English,
and restricted physical movement. A range of adherence
was observed during the study and we were unable to
understand this in detail. ASICA application, as currently
conﬁgured, will not suit everyone, but it may be possible
to tailor it to an individual need. While the developed
intervention may have greater value and relevance
among people familiar with technological advances, and
in localities where the clinical service is delivered to
patients remotely located from the clinical centre, it is
likely to have utility among a broad range of patients
after melanoma diagnosis and treatment. This view is
supported by noting that people with melanoma from
stage 0 to 2C were willing to take part.
These limitations must be viewed against the backdrop
of societal trends to embrace modern technology, and
an increasing appetite among clinicians and policy-
makers to diagnose and manage skin cancer using
digital means. A recent review, for example, identiﬁed
40 applications—with divergent quality and developmen-
tal rigour—for monitoring and diagnosis of pigmented
skin lesions.36
Context with other studies
Where interventions have been speciﬁcally developed to
improve TSSEs practice and subjected to randomised
trial, the results have been disappointing, although the
recruited patient groups have been different to this pilot
study. Two randomised trials, one in a general US
primary care population and another in Australian men
over 50 years of age, at increased risk but with no previ-
ous melanoma, educated using brochure or video
demonstrations only, reported increased TSSEs practice
for 3–7 months, with participation returning to baseline
after 1 year.14–17 A further study conducted among US
patients referred to a hospital pigmented lesion clinic,
reported signiﬁcant increases in TSSEs practice at 4
months when patients had received a educational
module and a personal skin map.18 Previous trials are
informative to the current intervention for three
reasons. First, all three were conducted for patients at
increased risk rather than for patients actually treated
for melanoma. It is, therefore, likely that the target
group of the ASICA intervention will be more motivated
to conduct and sustain TSSEs than previously studied
groups. Second, previous intervention development pro-
vides evidence that several of the components developed
using health psychology-based approaches and incorpo-
rated into ASICA application (such as the instructional
videos, personal skin maps, cues to action and sample
photographs) have the potential to promote and sustain,
at least in the short-term, TSSEs in patients who form a
lower risk group than the ASICA target population.14–18
Third, and perhaps most importantly, the interventions
previously trialled have comprised one-off educational
activities with the issue of videos, booklets or brochures
to patients for subsequent personal use.14–18 ASICA
application, on the other hand, will use familiar everyday
technology to prompt and sustain the behaviour over
time in the participant’s own homes, which should
increase the likelihood of success.37
Lessons learned from this study
Evidence for components of previous interventions that
have sustained TSSEs in the medium term have been
translated onto a theoretical intervention based on well-
evidenced theoretical models using the BCTs Taxonomy
v1 to implement the active behaviour change mechan-
isms.34 We found that an Experience Laboratory can
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provide rapid feedback on a developing theoretical
intervention, enabling it to be optimised for ﬁeld
testing. Finally, we have used carefully assembled theory
and knowledge to build a working prototype of an
actual digital intervention to support TSSEs by people
previously treated for cutaneous melanoma. This has
functioned well in a real-world pilot. It has succeeded in
actually supporting, and responding to TSSEs in a group
of patients who have appreciated and enjoyed using it.
We have found that it is a feasible and desirable inter-
vention. We are now aware about the minor modiﬁca-
tions that are required to proceed to a deﬁnitive clinical
trial employing the ASICA intervention. Such a trial,
conducted at several UK centres to ensure wider applic-
ability, should now follow shortly so that we can consoli-
date the promising ﬁndings reported here with
deﬁnitive evidence of ASICA application’s role in future
melanoma follow-up.
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